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Abstract
Background and Purpose: Amnestic mild cognitive impairment (aMCI) is a putative prodromal stage of Alzheimer’s disease
(AD) characterized by deficits in episodic verbal memory. Our goal in the present study was to determine whether executive
dysfunction may also be detectable in individuals diagnosed with aMCI.
Methods: This study used a hidden maze learning test to characterize component processes of visuospatial executive
function and learning in a sample of 62 individuals with aMCI compared with 94 healthy controls.
Results: Relative to controls, individuals with aMCI made more exploratory/learning errors (Cohen’s d=.41). Comparison of
learning curves revealed that the slope between the first two of five learning trials was four times as steep for controls than
for individuals with aMCI (Cohen’s d=.64). Individuals with aMCI also made a significantly greater number of rule-break/
error monitoring errors across learning trials (Cohen’s d=.21).
Conclusions: These results suggest that performance on a task of complex visuospatial executive function is compromised
in individuals with aMCI, and likely explained by reductions in initial strategy formulation during early visual learning and
‘‘on-line’’ maintenance of task rules.
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Introduction
In older adults, amnestic mild cognitive impairment (aMCI) is
classified on the basis of objective evidence of specific and
relatively large (i.e. .1 to 1.5 standard deviations) impairment in
episodic memory, self- or informant-reported problems in memory
but intact activities of daily living and mood [1,2]. Neurobiological
evidence is mounting that aMCI represents the earliest stages of
Alzheimer’s disease (AD) in the majority of patients [3,4,5].
Neuropsychological models of aMCI emphasize specific impair-
ment in episodic verbal memory such that the presence of
impairment in additional cognitive domains requires an alternative
diagnosis such as multiple-domain MCI, whose pathophysiological
and prognostic models are less clear compared with aMCI [6,7,8].
Given that mild AD is typically characterized by impairment in
memory, the importance of specific memory impairment to both
clinical models of aMCI is clear. However, there is now growing
evidence that executive functions may also be reduced in
individuals who meet clinical criteria for aMCI, albeit at a
magnitude not large enough to satisfy criteria for multiple-domain
MCI. For example, Brandt and colleagues found that individuals
with aMCI were worse on measures of planning/problem solving
and working memory, but not judgment (e.g. Iowa Gambling Test),
relative to healthy controls [9]. The magnitude of these
impairments relative to controls was small to moderate (e.g.,
Cohen’s d=0.46 for planning/problem solving and Cohen’s
d=.49 for working memory). As would be expected, individuals
with multiple-domain aMCI had more pronounced reductions in
planning/problem solving and working memory than individuals
with single domain aMCI. Taken together, results of these studies,
coupled with findings suggesting that executive dysfunction is
related to functional impairment in older adults [10,11], under-
score the importance of understanding the nature of executive
dysfunction in aMCI. In fact, some researchers have concluded
that only when executive function becomes impaired should an
MCI patient be considered to have prodromal AD [12,13].
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function in patients with MCI is typically small, it is important for
three reasons. First, elucidation of aspects of executive function
that are reduced in aMCI may show how other cognitive systems
in addition to memory may break down in the dementia
prodrome. For example, individuals with aMCI who have
executive dysfunction may have difficulty organizing material at
the level of encoding, strategically retrieving information, and
overcoming the effects of interference [14,15,16]. Second,
impairment in aspects of executive function may provide insight
into bases for memory impairment. For example, a recent study by
Chang and colleagues found that individuals with MCI who
scored higher on measures of executive function (Trail Making
Test and Digits Backward) performed better on a measure of
episodic verbal memory compared to individuals with MCI who
scored lower on measures of executive function [17]. One
explanation for this association is that executive function may
help to facilitate cognitive processes involved in verbal learning
(e.g. use of strategies such as semantic clustering) and may help
explain impairment on measures of verbal and visuospatial
learning and memory in individuals with MCI. Finally, given that
performance on tasks of complex executive function requires the
coordination of multiple cognitive operations including memory,
poor performance on these tasks may merely be the consequence
of the memory dysfunction that warranted the clinical classifica-
tion (i.e., forgetting test rules). That said, the relatively moderate
nature of the executive reductions found in individuals with aMCI
may also reflect very early changes in prefrontal cortical systems,
which are hypothesized to be necessary for normal executive
functions.
Many of the tasks used to assess complex executive function in
aMCI are limited in the extent to which performance can be
understood in terms of component cognitive operations such as
aspects of executive function and learning/memory [18]. Never-
theless, recent studies using hidden pathway maze learning to
study executive function [19,20] have shown that the computer-
ized administration and scoring of these tasks (e.g., the Groton
Maze Learning test [GMLT]) allows analysis of the extent to
which learning/memory and executive processes contribute to
overall performance [19,20,21]. Hidden pathway maze learning as
assessed by the GMLT requires individuals to learn the location of
a complex maze pathway hidden beneath a 10x10 grid of tiles over
successive learning trials. Individuals are trained on a set of rules
that facilitate search prior to attempting the maze and during
performance these rules are reinforced by error signals made
whenever a choice made contravenes one of these rules. On the
initial learning trial, individuals locate the pathway using a trial-
and-error search strategy conducted within the context of the pre-
learned rules. As the pathway is found across repeated trials, a
representation of the pathway location in memory strengthens and
can then be integrated with the application of the maze rules to
facilitate navigation of the pathway. Thus, optimal performance
on this task reflects the ability of individuals to combine rule
application with representations of a hidden maze pathway in
spatial memory. Further, the errors made across successive
learning trials can be classified as reflecting contravention of the
maze rules (i.e., rule break errors) or as errors in remembering the
maze pathway (i.e., exploratory errors).
There is growing evidence for the independence of these two
error types. For example, challenge with scopolamine, a
cholinergic antagonist, in healthy adults is associated with large-
magnitude performance deficits on the Groton Maze Learning
Test in healthy older adults. Importantly, the deleterious effects of
scopolamine were more pronounced for rule break/error
monitoring errors than for exploratory/learning errors, suggesting
that inhibition of cholinergic neurotransmission may affect
executive functions to a greater extent than spatial memory
functions [21]. In children with attention-deficit/hyperactivity
disorder (ADHD), poor performance on the GMLT arises because
these children make more rule-break errors than age-matched
children, whereas no differences between children with ADHD
and controls are observed for exploratory errors. Further, in
children with ADHD, stimulant medication reduced rule break
errors but did not alter rates of exploratory errors [22]. In contrast,
in healthy adults, poor performance on the GMLT under low-
level alcohol intoxication was due predominately to an increase
exploratory errors but not rule break errors, suggesting that
modulation of gamma aminobutyric acid (GABA) neurotransmis-
sion affected spatial learning more so than executive function [23].
Taken together, these data suggest that hidden pathway maze
learning may provide a useful neuropsychological probe to
understand the nature of subtle reductions in aspects of
visuospatial executive function and learning that occur in aMCI.
The aim of this study was to examine complex executive
function and learning in a well-characterized sample of individuals
with aMCI using a hidden pathway maze learning task and to
determine the extent to which impairment on this measure of
complex executive function reflects the contribution of executive
or spatial learning processes. Given that adults with aMCI have
substantial impairments in episodic memory, we hypothesized that
poor performance on the Groton Maze Learning Test in older
adults with aMCI would reflect predominantly dysfunction of
component spatial memory processes.
Materials and Methods
Participants
Participants were pooled from the control arms of four separate
pharmaceutical trials occurring between 2003–2007 with sites in
Syracuse (New York, USA), Toronto (Ontario, Canada), Austin
(Texas, USA) and Melbourne (Victoria, Australia). They were
recruited through newspaper advertisements for ‘‘studies on
human memory’’ at the respective sites. The protocol was
approved by the Western Institutional Review Board for the US
sites and by the Ethics Review Board of the University of Brisbane
for the Australian site. All participants provided written informed
consent prior to participating in this study. For all four of these
studies, participant inclusion and exclusion criteria as well as study
recruitment and procedures were identical (described below). The
goal of recruitment for these trials was to obtain an exceptionally
well-characterized and ‘clean’ sample of patients with aMCI.
Data were collected for a total of 156 elderly adults between the
ages of 55 and 90 (Mean age=68.5; 43.6% male), 62 of whom
were diagnosed with amnestic mild cognitive impairment (aMCI)
and 94 of whom were classified as healthy elderly (HE).
Demographic characteristics of these groups are shown in Table 1.
The following inclusion criteria for participants were followed in
all four studies: 1) all participants were physically healthy as
defined by no clinically relevant abnormalities identified by a
detailed medical history and full physical examination (including
blood pressure and heart rate measurement, 12-lead EEG and
clinical laboratory tests); 2) all participants obtained a head CT or
MRI within 12 months of testing, which showed no evidence of
infection, infarction, or other focal lesions that could result in
dementia; 3) all participants scored 12 or less on the 17-item
Hamilton Depression Rating Scale; 4) all participants scored
between 24 and 30 on the Mini-Mental State Exam; 5) all
participants obtained scores of no more than .5 on the Clinical
Visuospatial Executive Function
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Memory Score Box [25]; and 6) all participants presented with
general cognitive and functional performance sufficiently pre-
served such that the site physician could not make a diagnosis of
Alzheimer’s disease at the time of the screening visit. Criteria for
those in the aMCI group, in addition to those outlined above,
include 1) participants diagnosed with aMCI reported memory
complaints and memory difficulties verified by an informant and 2)
participants diagnosed with aMCI exhibited abnormal memory
function documented by scoring at least 1 standard deviation
below the education- and age-adjusted cut-off on the Logical
Memory II subscale (Delayed Paragraph Recall) from the
Wechsler Memory Scale-Revised with preserved performance in
other cognitive domains (within 1 standard deviation of age and
education adjusted means). Scores on cognitive tests used to
classify groups are shown in Table 2.
Participants were excluded if they displayed 1) evidence or
history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric,
neurological, or allergic disease; 2) uncontrolled hypertension; 3)
current depression or a history of major depression or another
major psychiatric disorder as described in the Diagnostics and
Statistics Manual- Version IV (DSM-IV) within the past 2 years; 4)
history of regular alcohol consumption exceeding 7 drinks/week
for women or 14 drinks/week for men within 6 months of
screening or 5) history of substance abuse or dependence within
the past 2 years (DSM-IV criteria). Study recruits were excluded if
they were using the following medications: anti-Parkinsonian
medications or anti-convulsants within 2 months prior to
screening, neuroleptics or narcotic analgesics, long-acting benzo-
diazepines or barbiturates, warfarin (Coumadin), antidepressants,
nitrates, phosphodiesterase inhibitors, sympathomimetic agents for
asthma control, ocular glaucoma drops, centrally active beta-
blockers, narcotics, methyldopa and clonidine, or medications with
significant cholinergic or anticholinergic side effects within 4 weeks
prior to screening, short-acting anxiolytics or sedative hypnotics
more frequently than 2 times per week within 4 weeks prior to
screening, or systemic corticosteroids within 3 months prior to
screening.
The Groton Maze Learning Test (GMLT)
The GMLT, originally developed by one of the authors (P.J.S.),
has been well-described elsewhere [26]. Briefly, this test begins
with a ‘‘timed chase test’’ and is then followed by the hidden maze
learning task. The timed chase test is a measure of simple
visuomotor processing speed that uses the same touchscreen input
device and spatial array of grey ‘‘tiles’’ as the maze test, but
without the maze-learning component. Participants are shown a
10610 grid of tiles on a computer touch screen (see Figure 1) and
they are asked to ‘chase the target,’ a blue tile that moves
erratically around the grid. As the target moves, the participant
‘chases’ it by tapping on the tiles one at a time (essentially, playing
a game of ‘follow the leader’). They are instructed to follow the
following rules: 1) no diagonal moves; 2) no skipping tiles; 3) after
an incorrect move, return to the last correct tile, and 4) do not tap
twice on the same tile. Once completing the untimed practice task,
the number of correct moves made during a second 30-sec trial is
used as an index of visuomotor speed. This metric is used as a
covariate to control for the potentially confounding influence of
visuomotor processing speed on GMLT performance.
To complete the hidden maze task, the participant must learn a
hidden pathway of 28 moves and 11 turns through the 10610 grid
from the top left corner to a finish marker in the bottom right
corner. They must follow the same four rules listed above.
Message bars and a musical tone indicate correct versus incorrect
moves, and the participant is instructed to either ‘go on’ or move
back to the last correct tile. Participants complete the trial five
times, in rapid uccession, to learn the same hidden path. Several
error types are recorded, including ‘legal’ or exploratory errors
(errors made while following rules; measure of maze memory),
perseverative errors (an exploratory error made repeatedly on a
consecutive trial), and ‘‘rule-break errors’’ (defined as errors made
in contravention of standard GMLT rules: i.e., no moving
diagonally, skipping tiles, failing to return to the last correct move
after an error, do not tap twice on the same tile). These measures
are generated for the five learning trials, as well as for the delayed
recall trial. A savings scores, which is the difference in total moves
between the fifth learning trial and the delayed recall trial is also
computed [20]. All mazes contain an equal number of moves with
no tiles revisited in a single maze. Each participant completed a
randomly generated maze. To control for ‘task familiarity effects,’
all participants completed two GMLT practice sessions using
different mazes within one week prior to their baseline exams. The
GMLT is available for both research and clinical use, by
contacting the test vendor, CogState, Ltd., at www.cogstate.com.
Data Analysis
Demographic characteristics of the aMCI and HE groups were
compared using independent-samples t-tests or chi-square tests.
GMLT outcome measures were computed according to previously
Table 1. Demographic characteristics of healthy elderly and
aMCI groups.
Healthy Elderly aMCI Statistical test
N9 2 5 9
Age 67.4 (SD=8.8) 69.9 (SD=8.1) t(149)=1.81, p=.072
Sex (%male)* n=32 (34.8%) n=32 (54.2%) x
2(1)=5.57, p=.018
Years of education 12.9 (SD=3.9) 12.1 (SD=3.0) t(149)=1.67, p=.10
Note: aMCI=Mild cognitive impairment-amnestic subtype; SD=standard
deviation.
*Groups differ, p,.05.
doi:10.1371/journal.pone.0021688.t001
Table 2. Neuropsychological tests used to classify Healthy
Elderly and aMCI groups.
Mean (SD)
Healthy Elderly aMCI
Mini Mental State Exam*+ 29.2 (1.01) 27.7 (1.35)
Rey Osterrieth Complex Figure Copy* 33.0 (2.43) 31.0 (4.75)
ROCF 3 min delay* 19.0 (6.14) 17.0 (5.39)
ROCF 30 min delay*+ 18.0 (4.59) 13.0 (4.00)
Wechsler Memory Scale Logical
Memory Delayed*+
12.0 (2.11) 8.0 (2.57)
Rey Auditory Verbal Learning
List A- Immediate*+
10.0 (2.75) 6.0 (2.93)
RAVLT List A- Delayed*+ 10.0 (2.76) 6.0 (3.24)
*Groups differ, p,.05, +aMCI group impaired (mean performance more than 1
SD below healthy elderly mean performance), SD=standard deviation,
aMCI=Amnestic mild cognitive impairment.
doi:10.1371/journal.pone.0021688.t002
Visuospatial Executive Function
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21688defined operationalizations of component cognitive processes
assessed by the task [27]. Non-normally distributed measures
(e.g., perseverative and rule-break errors) were transformed using
logarithmic (log10) transformations prior to analysis. GMLT
performance was analyzed using analyses of covariance (AN-
COVA) with group (HE vs. aMCI) and demographic character-
istics that differed between groups entered as covariates. A
univariate ANCOVA was conducted to analyze performance on
the timed chase test of the GMLT, with group (HE vs. aMCI)
entered as a fixed factor and age and sex as covariates.
Multivariate ANCOVAs were conducted to analyze performance
on GMLT measures of exploratory, perseverative, and rule-break
errors, differences in exploratory errors, and learning slopes; age,
sex, and timed chase test scores were entered as covariates in this
analysis; a separate ANCOVA was conducted with delayed recall
measures entered as dependent variables. Cohen’s d [28] values
were computed to estimate magnitudes of group differences.
Results
As shown in Table 1, age did not differ between groups. The
groups differed with respect to sex, with slightly more males in the
aMCI group. Age and sex were entered as covariates in analyses of
GMLT scores.
A univariate ANCOVA revealed that the aMCI group made
fewer moves per second on the timed chase test (28.996.79 vs.
33.896.79; F(1,146)=15.53, p,.001, d=.69) compared with
healthy controls. Greater age was also associated with perfor-
mance on the timed chase test (F(1,146)=136.63, p,.001;
r=2..69, p,.001), but sex (F(1,146)=.95, p=.33), and the
interaction of group x sex (F(1,146)=.00, p=.95, were not
significant. Accordingly, to control for the effect of differences in
visuomotor processing speed, timed chase test scores were entered
as a covariate in a multivariate analysis of GMLT performance
measures.
A MANCOVA of GMLT learning measures revealed a
significant overall effect of group [F(5,143)=2.86, p=.012]; age
[F(5,143)=3.67, p=.004] was also significantly associated with
GMLT learning measures, but sex [F(6,143)=1.23, p=.30],
timed chase test scores [F(5,143)=.57, p=.72], and interactions of
group x age [F(5,143)=1.86, p=.11], group x sex [F(5,143)=.22,
p=.97], and group x timed chase test scores [F(5,143)=2.11,
p=..07] were not significant. As shown in Table 3, the aMCI
group made more exploratory and rule-break errors than the
healthy control group, and differed significantly on a measure of
the learning slope from trial 1 to 2. The groups did not differ with
respect to perseverative errors.
Figure 2 shows learning curves for total number of exploratory
and rule-break errors on the GMLT for the aMCI and healthy
control groups. The healthy control group showed a more
substantial improvement in performance on the GMLT 2
nd
learning trial, suggesting greater benefit from the first exposure to
solving the hidden maze compared to the aMCI group. In the
healthy control group, the slope of the learning curve (accuracy)
over trials 1 to 2 was four times as steep as that observed for the
aMCI group; however, the difference in slopes from trials 3 to 5
was not significant. A similar pattern of performance was observed
for rule-break errors.
Figure 1. The Groton Maze Learning Test: Stimulus and Examples of Error Types. Tiles shaded in gray represent one of the hidden maze
pathways on the GMLT; numbers indicate order of moves for a sample participant; Move 2 to 3 (shown in black): exploratory error; Move 3 to 4
(shown in red): rule-break error (tapping on same tile twice); Move 8 to 9 (shown in green): perseverative error; Move 12 to 13 (shown in grey): rule
break error (not moving back to the last correct tile); Move 16 to 17 (shown in blue): rule break error (no moving diagonally); Move 20 to 21 (shown in
purple): rule break error (moving backwards along the maze).
doi:10.1371/journal.pone.0021688.g001
Visuospatial Executive Function
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recall trial did not reveal a significant effect of group
[F(4,140)=.68, p=.60) or any of the other main effects of
interactions [all F’s(4, 140),1.97, all p’s..10]. As shown in the
bottom panel of Table 3, none of the delayed recall measures,
including exploratory errors, perseverative errors, rule-break
errors, and savings scores, differed by group.
Discussion
The purpose of this study was to use a hidden maze learning
task to analyze component processes of executive function and
spatial learning dysfunction in a well-characterized sample of
individuals with aMCI. Results of this study showed that, relative
to healthy controls, individuals with aMCI made significantly
more learning (exploratory) and working memory (rule-break)
errors during the initial, acquisition trials of the task. We had
hypothesized that the aMCI group would perform more
exploratory errors given their primary amnestic syndrome, but
found that they also made a significantly greater number of rule-
break errors compared to healthy controls. This finding suggests
that reductions in aspects of executive function (e.g., error
monitoring) may in fact be present in a group otherwise identified
as single-domain amnestic MCI using more conventional
neuropsychological measures. These results further suggest that
performance on a task of complex visuospatial executive function
is compromised in individuals with aMCI, and likely explained by
reductions in initial strategy formulation during early stages of
visual learning.
Compared to the healthy control group, the aMCI group
differed in the processes by which they learned the hidden maze
path. In addition to having greater difficulty with initial strategy
acquisition (i.e., making a greater number of rule-break errors), the
aMCI group evidenced a substantially less steep learning curve
from the first to second learning trial of the maze. Nevertheless,
there was no statistically significant difference in mean errors
between groups from the third to fifth learning trial, which
indicates that while the aMCI group had difficulty in their initial
acquisition strategy and developing an internal spatial map, this
did not affect their ability to eventually learn the hidden pathway
over later trials; this interpretation is further supported by the fact
that the groups did not differ on any of the delayed recall
measures. Given that the aMCI group scored lower but not in the
impaired range compared tothe healthy control group on the
ROCF-Copy (see Table 2), reduced visual organization may
account for reductions in initial strategy acquisition and encoding
of a hidden maze pathway on the Groton Maze Learning Test.
Results of the current study extend previous research [14,15,16] to
suggest that aMCI patients may have difficulty with the
organization and initial encoding of visual information. Individuals
with aMCI also made more exploratory and rule-break errors than
healthy controls, with the magnitudes of the effect sizes of these
group differences (d’s=.41 and .21, respectively) comparable to a
previous study of executive function in aMCI. For example,
Brandt and colleagues [9] found that individuals with aMCI
performed more poorly on tests of working memory (e.g., Trail
Making Test Part B-A) and planning/problem solving (e.g.,
Porteus Maze), and that the magnitudes of these differences were
moderate (i.e., d’s=.49 and .46, respectively). Importantly, results
of the current study suggest that employment of a cognitive test
that yields several performance measures may yield greater insight
into component visuospatial learning and executive processes that
may be reduced in aMCI. For example, the most pronounced
performance decrement observed in the current study was for the
learning slope of exploratory/learning errors made over the first
two learning trials (d=.64). This finding suggests that difficulties
with efficient encoding—remembering the hidden pathway while
following the rules—during early visual learning may account for
reduced visual learning in individuals with aMCI.
The finding that the aMCI group made an increased number of
errors reflecting both working memory (i.e., rule-break errors) and
spatial learning (i.e., exploratory errors) processes is consistent with
an earlier study of healthy older adults in which we observed
relatively greater increases in errors reflecting these processes
following low dose administration of the muscarinic acetylcholine
antagonist scopolamine [21]. Results of this study suggested that
scopolamine administration was associated with a pronounced
(d.1.5) reduction in both the acquisition and application of the
general rules (i.e. rule-break errors), spatial learning (i.e.
exploratory errors), and error monitoring (i.e., perseverative
errors) on the Groton Maze Learning Test. In the current study,
Table 3. Means and standard errors for Groton Maze Learning Test (GMLT) outcome measures in Healthy Elderly and aMCI groups.
Healthy Elderly aMCI Statistical tests Cohen’s d
Learning Trials
Exploratory Errors* 56.13 (1.98) 63.87 (2.39) F(1,145)=5.84, p=.017 .41
Perseverative Errors 4.84 (.54) 5.70 (.65) F(1,145)=2.79, p=.097 .17
Rule-break errors* 2.31 (.38) 3.06 (.45) F(1,145)=4.40, p=.038 .21
Learning Slope: difference in exploratory
errors (Trial 1-Trial 2)*
5.01 (.65) 1.10 (.78) F(1,145)=14.04, p,.001 .64
Learning Slope: difference in exploratory
errors (Trial 3- Trial 5)
2.26 (.48) 2.69 (.57) F(1,145)=.32, p=.57 .10
Delayed Recall Trial
Exploratory Errors 7.53 (.46) 8.49 (.56) F(1,145)=1.66, p=.20 .22
Perseverative Errors .74 (.13) .63 (.15) F(1,145)=.30, p=.58 .09
Rule-break errors .36 (.08) .31 (.10) F(1,145)=.13, p=.71 .07
Savings score 2.55 (.61) 21.71 (.73) F(1,145)=1.17, p=.28 .20
Note: Values adjusted for age, sex, and timed chase test scores.
*Groups differ, p,.05, aMCI=amnestic mild cognitive impairment.
doi:10.1371/journal.pone.0021688.t003
Visuospatial Executive Function
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rule-break errors compared to healthy controls, but did not differ
with respect to perseverative errors. Importantly, magnitudes of
the group differences observed in the current study were much
smaller than those observed in the scopolamine study. One
explanation for this finding is that targeted muscarinic acetylcho-
line receptor antagonism with scopolamine gives rise to much
more pronounced and widespread reductions in performance
across all GMLT performance measures (d’s.1.50), while
individuals with aMCI may show less pronounced, albeit clinically
meaningful, decrements in GMLT performance relative to
controls (d’s=.17 to .41). While additional research is needed to
elucidate neurobiological changes that may account for these
observed performance decrements in aMCI, results of this
previous study that used scopolamine as a model of early AD
suggests that reduced performance on GMLT measures of
exploratory and rule-break errors may arise from disruption to
cholinergic neurotransmission. The finding in the current study
that the aMCI group made a greater number of rule-break errors
compared with the healthy control group suggests that reduced
performance on the GMLT may reflect difficulty in the acquisition
and/or application of test rules, as well as in using information
held in working memory to facilitate spatial learning and memory
performance on this task.
The aMCI group did not evidence robust improvement in
performance on the second trial of the hidden maze task compared
to the healthy control group. Previous studies using the Groton
Maze Learning Test have noted that the first learning trial is
distinguished from all subsequent trials because for this first trial
the hidden path is entirely unknown, as the participant is
beginning to develop an internal spatial map of the hidden path
by following the task rules and making exploratory errors [29,30].
In fact, Mathewson and associates [29] showed differences
between the first and subsequent learning trials in both the
amplitude and latencies of the feedback-related negativity (FRN)
potential, generated over the region of the anterior cingulate
gyrus, when participants receive a signal that they have made an
error. Given that the feedback for rule use is constant across all
trials of the Groton Maze Learning Test and that the hidden path
remains unchanged from trial to trial within a given test
administration, the major difference in performance between the
first and second trials is that on the second trial, individuals have
been primed by a first exposure to the path, which must be held in
working memory in order to successfully complete subsequent
trials.
Neuroimaging studies suggest a possible neural basis for the
findings observed in this study. For example, studies have shown
that the hippocampus is active during the encoding of new spatial
information [31] and that in individuals with aMCI, hippocampal
activation may be reduced, with compensatory activation of
anterior cingulate and medial frontal cortex [32]. For example, a
positron emission tomography study found that while healthy
controls evidenced predominantly left frontal activity and posterior
cingulate activity during the encoding trials of an episodic memory
task, and right frontal plus left temporal activity during retrieval,
individuals with MCI did not demonstrate this pattern of
activation and instead showed compensatory increases in activa-
tion in the occipital cortex during encoding and left frontal lobe
during retrieval [33]. More research using neuromaging measures
during the Groton Maze Learning Test performance is needed to
examine the neural correlates of visuospatial executive function
and learning on this task.
Neuroanatomical changes are seen relatively early in amnestic
MCI patients in both the hippocampus and entorhinal cortex,
which are associated with learning and integrating information
[34]. Emerging research has also suggested that thickness in
numerous regions of frontal cortex and bilateral posterior
cingulate is associated with increased episodic memory perfor-
mance above and beyond the contribution of the mesial temporal
regions associated with episodic memory in individuals with MCI.
Further, individuals with aMCI who scored low on measures of
executive function showed greater cortical thinning in these same
brain regions relative to those who scored higher on measures of
executive function despite equivalent hippocampal volumes and
thickness of mesial temporal lobe regions [17]. Taken together,
these studies suggest a complex interplay between brain regions
implicated in both executive function, and learning and memory
in individuals with aMCI.
Although performance on the Groton Maze Learning Test is
associated with hippocampal functioning similar to three-dimen-
sional navigation tasks, this test is two-dimensional and does not
require egocentric orienting. However, given the GMLT’s
association with a virtual reality navigation task [35] and other
non-egocentric tasks such as block tapping and complex figure
Figure 2. Mean Exploratory Errors and Rule Break Errors (with Standard Errors) over five learning trials of the Groton Maze
Learning Test in Healthy Controls versus aMCI groups.
doi:10.1371/journal.pone.0021688.g002
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formation of internal pathways relates to formation of internal
maps; this is particularly relevant in studies of aMCI and AD,
given declines in hippocampal integrity, as well as learning and
memory function.
Methodological limitations of this study must be noted. First,
both a strength and limitation of this study is the well-
characterized sample of individuals with aMCI. This represents
a strength inasmuch as the highly screened sample ensures that
comorbid medical, neurologic, and/or psychiatric conditions do
not confound the observed associations; it represents a limitation,
as it is not clear whether results of this study are generalizable to
the broader population of individuals with aMCI, who often
present with comorbidities [9]. Second, this study focused solely on
characterizing component processes of visuospatial executive
function and learning in individuals with aMCI. Whether results
of this study differ in other subtypes of MCI, such as non-amnestic
MCI or multi-domain amnestic MCI remains to be examined.
Based on previous research, which has demonstrated more
pronounced reductions in planning/problem solving and working
memory in non-amnestic and multi-domain MCI [9], individuals
with these subtypes of MCI may experience more difficulties in
with the acquisition of novel and complex spatial information.
Despite these limitations, results of the current study provide an
example of how component visuospatial executive and learning
processes involved in the performance of certain neuropsycholog-
ical tasks may help develop a more refined understanding of the
cognitive pathology of different types of MCI and ultimately of
pre-MCI elderly at risk for dementia.
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